Inhibition of NF-κB in fusogenic membrane glycoprotein causing HL-60 cell death: Implications for acute myeloid leukemia

Cancer Letters

Volumn 273, Issue 1, 2009, Pages 114-121

  Tan, Li ^a   Jia, Hongyun ^a   Liu, Ranyi ^a   Wu, Jiangxue ^a   Han, Hongyu ^a   Zuo, Yufang ^a   Yang, Shiping ^a   Huang, Wenlin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

FMG; HSP70; NF B; Nuclear translocation; Syncytia

Indexed keywords

HEAT SHOCK PROTEIN 70; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; VIRUS ENVELOPE PROTEIN; MEMBRANE PROTEIN; VIRUS FUSION PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DEATH; CELL FUSION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; NECROSIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIUM; VIRAL GENE DELIVERY SYSTEM; CELL STRAIN HL 60; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; GIANT CELL; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PLASMID; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

GIBBON APE LEUKEMIA VIRUS;

CELL DEATH; CELL FUSION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; GIANT CELLS; HL-60 CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LEUKEMIA VIRUS, GIBBON APE; LEUKEMIA, MYELOID, ACUTE; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; PLASMIDS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; UP-REGULATION; VIRAL FUSION PROTEINS;

EID: 56349096250     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.07.035     Document Type: Article

References (30)

1. Wang J.C.Y., and Dick J.E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15 (2005) 494-501
2. Guzman M.L., Neering S.J., Upchurch D., Grimes B., Howard D.S., Rizzieri D.A., Luger S.M., and Jordan C.T. Nuclear factor kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 98 (2001) 2301-2307
3. Costello R.T., Mallet F., Gaugler B., Sainty D., Arnoulet C., Gastaut J.A., and Olive D. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 60 (2000) 4403-4411
4. Gómez-Navarro J., Curiel D.T., and Douglas J.T. Gene therapy for cancer. Eur. J. Cancer 35 (1999) 2039-2057
5. Freeman S.M., Abboud C.N., Whartenby K.A., Packman C.H., Koeplin D.S., Moolten F.L., and Abraham G.N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53 (1993) 5274-5283
6. Pope I.M., Poston G.J., and Kinsella A.R. The role of the bystander effect in suicide gene therapy. Eur. J. Cancer 33 (1997) 1005-1016
7. Bateman A., Bullough F., Murphy S., Emiliusen L., Lavillette D., Cosset F.L., Cattaneo R., Russell S.J., and Vile R.G. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res. 60 (2000) 1492-1497
8. Johnson K.J., Peng K.W., Allen C., Russell S.J., and Galanis E. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction. Gene Ther. 10 (2003) 725-732
9. Higuchi H., Bronk S.F., Bateman A., Harrington K., Vile R.G., and Gores G.J. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy. Cancer Res. 60 (2000) 6396-6402
10. Melcher A., Todryk S., Hardwick N., Ford M., Jacobson M., and Vile R.G. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4 (1998) 581-587
11. Tamura Y., Peng P., Liu K., Daou M., and Srivastava P.K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278 (1997) 117-120
12. Gores G.J., Nieminen A.L., Fleishman K.E., Dawson T.L., Herman B., and Lamasters J.J. Extracellular acidosis delays onset of cell death of ATP-depleted hepatocytes. Am. J. Physiol. 255 (1998) C315-C322
13. Bortul R., Tazzari P.L., Cappellini A., Tabellini G., Billi A.M., Bareggi R., Manzoli L., Cocco L., and Martelli A.M. Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. Leukemia 17 (2003) 379-389
14. Petit P.X., Lecoeur H., Zorn E., Dauguet C., Mignotte B., and Gougeon M.-L. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130 (1995) 157-167
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
16. Aggarwal B.B. Nuclear factor-κB: the enemy within. Cancer Cell 6 (2004) 203-208
17. Wu Y., Qiu H., Zeng Y., You X., Deng Z., Yu M., and Zhu C. Mycoplasma genitalium lipoproteins induce human monocytic cell expression of proinflammatory cytokines and apoptosis by activating nuclear factor κB. Mediat. Inflamm. 10 (2008) 1155-1163
18. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev. 18 (2004) 2195-2224
19. Karin M., and Greten F.R. NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
20. Chen F., Castranova V., and Shi X. New Insights into the role of nuclear factor-κB in cell growth regulation. Am. J. Pathol. 159 (2001) 387-397
21. Velasco M., Díaz-Guerra M.J., Martín-Sanz P., Alvarez A., and Boscá L. Rapid up-regulation of IkappaB beta and abrogation of NF-kappaB activity in peritoneal macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 272 (1997) 23025-23030
22. Thanos D., Maniatis T., and NF-kappa B. A lesson in family values. Cell 80 (1995) 529-532
23. Agashe V.R., and Hartl F.U. Roles of molecular chaperones in cytoplasmic protein folding. Semin. Cell Dev. Biol. 11 (2000) 15-25
24. Hartl F.U., and Martin J. Molecular chaperones in cellular protein folding. Curr. Opin. Struct. Biol. 5 (1995) 92-102
25. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., and Alnemri E.S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2 (2000) 476-483
26. Beere H.M., Wolf B.B., Cain K., Mosser D.D., Mahboubi A., Kuwana T., Tailor P., Morimoto R.I., Cohen G.M., and Green D.R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2 (2000) 469-475
27. Steel R., Doherty J.P., Buzzard K., Clemons N., Hawkins C.J., and Anderson R.L. Hsp72 inhibits apoptosis upstream of the mitochondria and not through interactions with Apaf-1. J. Biol. Chem. 279 (2004) 51490-51499
28. Jo S.K., Ko G.J., Boo C.S., Cho W.Y., and Kim H.K. Heat preconditioning attenuates renal injury in ischemic ARF in rats: role of heat-shock protein 70 on NF-kappaB-mediated inflammation and on tubular cell injury. J. Am. Soc. Nephrol. 17 (2006) 3082-3092
29. Ran R., Lu A., Zhang L., Tang Y., Zhu H., Xu H., Feng Y., Han C., Zhou G., and Rigby A.C. Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev. 12 (2004) 1466-1481
30. Guzman M.L., and Jordan C.T. Considerations for targeting malignant stem cells in leukemia. Cancer Control 11 (2004) 97-104